FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN)

CUSIP: 35655L107

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / SPONSORED ADS
Total 13F shares
13,200,510
Share change
-542,978
Total reported value
$25,974,000
Price per share
$1.98
Number of holders
18
Value change
-$1,879,119
Number of buys
7
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 35655L107?
CUSIP 35655L107 identifies FRLN - FREELINE THERAPEUTICS HLDGS - SPONSORED ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN) as of Q4 2021

As of 31 Dec 2021, FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,200,510 shares. The largest 10 holders included EVENTIDE ASSET MANAGEMENT, LLC, Syncona Portfolio Ltd, CHI Advisors LLC, Novo Holdings A/S, Polygon Management Ltd., WELLINGTON MANAGEMENT GROUP LLP, AXA S.A., RENAISSANCE TECHNOLOGIES LLC, HARBOR CAPITAL ADVISORS, INC., and MARSHALL WACE, LLP. This page lists 18 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.